3D co-culture system to characterize and target leukemia stem cells
3D co-culture system to characterize and target leukemia stem cells
批准号:
10044631
负责人:
Monica L Guzman
金额:
$43.58万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-01 至 2024-02-29
关键词:
3-DimensionalAcute Lymphocytic LeukemiaAcute Myelocytic LeukemiaAffectAftercareBiological AssayBiological MarkersBiologyBone MarrowBone Marrow Stem CellCell CommunicationCell Culture TechniquesCell LineCell physiologyCellsClinicClinicalCoculture TechniquesComplexCuesDataDependenceDevelopmentDiseaseDrug EvaluationDrug resistanceEpigenetic ProcessEvaluationGeneticGenetic MarkersGoalsHematopoiesisHematopoietic stem cellsHeterogeneityHypoxiaImageIncidenceLaboratoriesLeukemic CellMalignant - descriptorMeasurementMesenchymalModelingMorbidity - disease rateMutationOrganoidsOutcomePathogenesisPatient CarePatientsPharmaceutical PreparationsPhenotypePlayPopulationPredispositionPropertyRecurrent diseaseRelapseResidual stateResistanceRoleSamplingSelection for TreatmentsSignal TransductionSpecific qualifier valueStromal CellsStructureSystemTestingTherapeuticacute myeloid leukemia cellantileukemic agentbaseburden of illnesscancer stem cellcancer therapycell stromadrug testingepigenetic markerimprovedindividual patientleukemic stem cellmesenchymal stromal cellmonolayermortalitynovelnovel strategiesnovel therapeutic interventionoptimal treatmentspatient populationpatient responseperipheral bloodpersonalized medicinepersonalized strategiespreventresponseself-renewalsingle cell sequencingstem cell therapystem cellsstemnesssuccesstargeted treatmenttreatment responsetreatment strategy
中文摘要
项目总结:
造血干细胞(HSCs)驻留在骨髓(BM)中,其功能受其调节。
与BM微环境的相互作用。白血病干细胞(LSC)已被证明能够
启动和维持急性髓系白血病(AML)和急性淋巴细胞白血病(ALL)。此外,
LSCs与其微环境的相互作用已被证明在抗性中起着关键作用
接受治疗的LSC。研究LSCs的传统方法及抗白血病药物对其影响
已经进行了2D单层细胞培养。随着复杂的细胞-基质相互作用继续被阐明,它是
显然,这种模式不再是BM利基市场错综复杂的充分代表。因此,
开发更好地模拟这种微环境的模型势在必行,既要研究LSC特性,
以及用于在反映微环境贡献的系统中测试药物效应。我们
假设一个能够概括BM生态位条件以维持LSC的培养系统将允许
为了更好地了解它们的生物学和发现新的治疗方法
黑石中的LSC。我们建议实施新的方法来评估BM-LSC相互作用,以改善
以患者特有的方式评估LSCs的功能、耐药性和干细胞特性。我们的
初步数据表明,3D球体(类器官结构)可以概括BM生态位特征,
比如缺氧。此外,我们观察到LSC得到了更好的维护并保留了功能
使用3D基质方法的茎特性与更传统的培养系统进行比较。因此,
我们建议评估AML(具有良好的突变特征)以确定其存活率。
在利基互动环境中的依赖关系。这个项目的最终目标是找出新的治疗方法
直接或通过破坏BM-LSC保护性相互作用来靶向LSC的方法。
英文摘要
PROJECT SUMMARY:
Hematopoietic stem cells (HSCs) reside in the bone marrow (BM) and their function is regulated by their
interactions with the BM microenvironment. Leukemia stem cells (LSCs) have been shown to be capable of
initiating and maintaining acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Furthermore,
the interactions of LSCs with their microenvironment have been shown to play a critical role in the resistance
of LSCs to therapy. The traditional approach of investigating LSCs and anti- leukemic agents’ effects on them
has been the 2D monolayer cell culture. As complex cell-matrix interactions continue to be elucidated, it is
clear that this model is no longer a sufficient representative of the intricacies of the BM niche. Thus, the
development of a model that better mimics this microenvironment is imperative, both to study LSC properties,
as well as for testing drug effects in a system that reflects the contributions of the microenvironment. We
hypothesize that a culture system capable of recapitulating the BM niche conditions to maintain LSCs will allow
for the better understanding of their biology and the discovery of novel therapeutic approaches that can act on
LSCs in the BM. We propose to implement novel approaches to evaluate BM-LSC interactions to improve the
assessment of the function, drug resistance and stem cell properties of LSCs in a patient-specific manner. Our
preliminary data suggest that the 3D spheroids (organoid-like structures) can recapitulate BM niche features,
such as hypoxia. In addition, we have observed that the LSCs are better maintained and retain functional
stemness properties using the 3D stromal approach compared to more conventional culture systems. Thus,
we propose to evaluate AML (with a well-characterized mutational profile) to determine their survival
dependencies in the context of niche interactions. The ultimate goal of this project is to identify new therapeutic
approaches to target LSCs either directly or through disruption of the BM-LSC protective interactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A role for elevated autophagy in survival and chemoresistance of leukemia stem ce
-
批准号:8441529
-
项目类别:
-
资助金额:$17.28万
-
财政年份:2012
-
负责人:Monica L Guzman
-
依托单位:
A role for elevated autophagy in survival and chemoresistance of leukemia stem ce
-
批准号:8244092
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2012
-
负责人:Monica L Guzman
-
依托单位:
Selection of Novel Therapies to Ablate Chemoresistant Myeloid Leukemia Stem Cell
-
批准号:7981799
-
项目类别:
-
资助金额:$253.5万
-
财政年份:2010
-
负责人:Monica L Guzman
-
依托单位:
Pharmacological modulation of epigenetic changes in AML
-
批准号:8645614
-
项目类别:
-
资助金额:$30.09万
-
财政年份:2004
-
负责人:Monica L Guzman
-
依托单位:
Pharmacological modulation of epigenetic changes in AML
-
批准号:8826033
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2004
-
负责人:Monica L Guzman
-
依托单位:
Pharmacological modulation of epigenetic changes in AML
-
批准号:8505766
-
项目类别:
-
资助金额:$32.29万
-
财政年份:2004
-
负责人:Monica L Guzman
-
依托单位:
Pharmacological modulation of epigenetic changes in AML
-
批准号:9116788
-
项目类别:
-
资助金额:$34.21万
-
财政年份:2004
-
负责人:Monica L Guzman
-
依托单位:
海外基金